From: Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trial
Change after exercise
Day 0
Day 90
Day 180
Pimobendan-group
81.5 (± 89.9)
56.0 (± 75)
−10 (± 39.09)
Placebo-group
120.7 (± 109)
137.7 (± 164.9)
152.2 (± 159.4)